MENLO PARK, Calif., February 27, 2013 - Geron Corporation (Nasdaq: GERN) today announced that Olivia Bloom, Senior Vice President, Finance, and Chief Financial Officer, will present an overview of the company at 10:40 a.m. Eastern Time on Wednesday, March 6, at the Cowen and Company 33rd Annual Health Care Conference in Boston.
A live webcast of the presentation will be available at http://wsw.com/webcast/cowen10/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
Geron is a biopharmaceutical company developing first-in-class therapies for cancer, including its telomerase inhibitor, imetelstat, in clinical development. For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations